Science & Education
RSNA is committed to helping transform patient care by making radiology a more quantitative science.
Quantitative imaging is the extraction of quantifiable features from medical images for the assessment of normal or the severity, degree of change, or status of a disease, injury, or chronic condition relative to normal. Quantitative imaging includes the development, standardization, and optimization of anatomical, functional, and molecular imaging acquisition protocols, data analyses, display methods, and reporting structures. These features permit the validation of accurately and precisely obtained image-derived metrics with anatomically and physiologically relevant parameters, including treatment response and outcome, and the use of such metrics in research and patient care.
QIBA is an initiative to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry. This involves:
The Quantitative Imaging Biomarkers Alliance (QIBA) was organized by RSNA in 2007 to unite researchers, healthcare professionals and industry stakeholders in the advancement of quantitative imaging and the use of biomarkers in clinical trials and practice.
QIBA Organizational Chart
Improve the value and practicality of quantitative imaging biomarkers by reducing variability across devices, patients and time.
The work of QIBA has advanced through the generous efforts of volunteer members from academia, the medical device, pharmaceutical and other business sectors, and government. There are four Modality Committees (Q-CT, Q-MR, Q-NM and Q-US) and 6 Technical Committees (CT Volumetry, COPD/Asthma, PDF-MRI, fMRI, FDG-PET & Ultrasound). All groups are open to interested persons. These Committees have specific tasks and deliverables for their respective modalities or disease-based approach.
Learn about the Profiles and Protocols developed and implemented through QIBA Technical Committees.
Learn more about the QIBA Metrology Working Group efforts to establish terminology and methodology guidelines for research use and clinical practice.
Understand how to identify a biomarker research opportunity using these essential guidelines.
Understand the defined, coordinated process for developing and adopting standards-based biomarkers.
Read articles and updates from technical committees and see how you can participate in QIBA-related activities.
Review presentations from RSNA and QIBA annual meetings, find resources from the IOM and visit the QIBA WIKI.